Cancer Vaccine Current Events | Cancer Vaccine News | 7
|
| Page
7 of
112 |
2229 Results |
|
|
|
Sort By:
Page Views | Date |
STEP HIV vaccine study to be unblinded
Merck & Co., Inc. and the HIV Vaccine Trials Network (HVTN) today announced that study volunteers in the STEP study of Merck's HIV vaccine (V520) will be told whether they received vaccine or placebo, and all study volunteers will be encouraged to continue to return to their study sites on a regular basis for ongoing risk reduction counseling... view more... (2007-11-14)
Different type of colon cancer vaccine reduces disease spread, Jefferson scientists show
Taking advantage of the fact that the intestines have a separate immune system from the rest of the body, scientists at the Kimmel Cancer Center at Jefferson in Philadelphia have found a way to immunize mice against the development of metastatic disease. view more (2008-06-25)
University and health science center in San Antonio collaborate to find chlamydia vaccine
It's the most common bacteria-related sexually transmitted disease in the United States, so researchers at The University of Texas at San Antonio's South Texas Center for Emerging Infectious Diseases (STCEID) and The University of Texas at San Antonio Health Science Center have partnered to discover a vaccine that will prevent Chlamydia. view more (2007-02-20)
Duke To Test Bird Flu Vaccine Dosing
A clinical trial to test different strengths of a vaccine designed to fight avian influenza will begin this month at Duke University Medical Center. view more (2006-03-31)
Scientists discover how to improve immune response to cancer at Princess Margaret Hospital
A team of scientists at The Campbell Family Institute for Breast Cancer Research (CFIBCR) at Princess Margaret Hospital and international collaborators have discovered how to trigger an improved immune response to cancer that could be included in new clinical trials that use a patient's own cells to destroy tumours. view more (2009-04-27)
Bird flu vaccine additive may stretch supply
Researchers have achieved an effective immune response to an avian influenza vaccine with doses as low as one-quarter of the norm when they added a chemical mixture known as MF59. view more (2006-09-26)
Smallpox Outbreak: How Long Would It Take for Vaccines To Protect People? Would it Work?
In the event of a smallpox outbreak in the United States, how long would it take for a vaccine to start protecting Americans by stimulating an immune response? A new national study led by Saint Louis University School of Medicine will attempt to answer this question. view more (2007-05-01)
New vaccine shows promise for COPD patients at risk for pneumonia
A new vaccine against pneumonia may offer better protection from chronic obstructive pulmonary disease (COPD) patients than the currently accepted vaccine, according to recent research that will be published in the September 15 issue of the American Journal of the Respiratory and Critical Care Journal, a publication of the American Thoracic... view more... (2009-09-08)
New gene silencing therapy for cervical cancer
Researchers at The University of Queensland's (UQ) Centre for Immunology and Cancer Research (CICR), based at the Princess Alexandra Hospital, have pioneered a new approach for the treatment of cervical cancer. view more (2005-11-17)
Experimental vaccine protects lab animals against several strains of H5N1
Nations are preparing to stockpile vaccines against H5N1, the strain of influenza virus that experts fear could cause the next flu pandemic. But will these vaccines remain effective as the virus mutates? view more (2006-06-14)
Assuring the supply of vaccines
The recent shortage of flu vaccine, which eventually became a surplus, points to problems with vaccine financing and production. Various solutions to these problems have been proposed, but there has been no consensus on the path to take. view more (2005-06-21)
New intranasal influenza vaccine triggers robust immunity with significantly less antigen
A single administration of a novel, nasally delivered influenza vaccine elicited immune responses in ferrets that were more than 20 times higher than those generated by two injections of the currently approved vaccines, according to a study by NanoBio Corporation. view more (2008-10-29)
EDCTP welcomes G8 support for HIV/AIDS vaccine development
On 10th June 2004 during this year's summit in Sea Island, Georgia, the G8 Leaders called for the establishment of a Global HIV Vaccine Enterprise: a virtual consortium to accelerate HIV vaccine development by enhancing coordination, information sharing, and global collaboration. The EDCTP is pleased to see this expression of support and... view more... (2004-06-11)
Risky Surgery Not Always Necessary to Treat Cervical Disease
Revolutionary advancements in the treatment options for diseases associated with human papillomavirus (HPV) now include nonsurgical options such as chemoprevention and vaccines. A review of these methods is published in the latest issue of the International Journal of Gynecological Cancer. view more (2005-03-23)
Study recommends strategies for distributing flu vaccine during shortage
When faced with potential vaccine shortages during a flu outbreak, public health officials can turn to a new study by mathematical biologists at The University of Texas at Austin to learn how to best distribute the vaccine. view more (2006-10-04)
Warts vaccine -- 1 of many in pipeline
A clinical trial treating the papillomaviruses responsible for genital warts was on target at the halfway mark, according to Australian of the Year 2006 Professor Ian Frazer and trial manager, sexual health specialist Dr David Jardine. view more (2007-05-10)
Cervical cancer screening: Too many are left unprotected
The decline in cervical cancer is a success story of cancer research. Although there are reasons to be optimistic about even further decreases in cervical cancer incidence, there still remain some women who are not screened. view more (2007-09-20)
Number of cases of most vaccine-preventable diseases in US at all-time low
A comparison of illness and death rates for 13 vaccine-preventable diseases in the U.S., before and after use of the vaccine, indicates there have been significant decreases in the number of cases, hospitalizations and deaths for each of the diseases examined. view more (2007-11-14)
Promising preclinical results with live attenuated H5N1 vaccines
Several approaches are in progress to develop vaccines against the avian flu variety of the influenza virus. Kanta Subbarao (National Institutes of Health) and colleagues are working on live attenuated vaccines, which have the potential to elicit a strong, broad, and lasting immune response. view more (2006-09-12)
Producing flu vaccines will be faster and cheaper, thanks to MSU technology
Technology from Michigan State animal science labs looks to produce new human flu vaccines quicker and cheaper than current methods. view more (2006-07-12)
|
|
| Page
7 of
112 |
2229 Results |
|
|
|
Sort By:
Page Views | Date |
|
